Invuity’s patented Intelligent Photonics® devices provide direct visualization of the surgical cavity enabling enhanced precision, efficiency and safety. Our technology is integrated into sophisticated retractor systems, handheld devices and intracavity drop-in illuminators; each utilizing our proprietary waveguide technology that directs and shapes light into broad, uniform illumination to provide enhanced direct visualization inside dark surgical cavities. In addition, it converts traditional thermally hot, concentrated light output to thermally cool volumetric illumination throughout the entire surgical cavity.
Transforming Minimal access Surgeries Through Advanced Visualization
Invuity is committed to leveraging advanced photonics technology to transform and create a new standard of care for minimal access surgery.
SAN FRANCISCO, May 29, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced that company management is scheduled to present at the 38th Annual Growth Stock Conference on Tuesday, June 12, 2018 at 9:30 a.m. Central Time in Chicago. A live, listen-only webcast of the presentation may be accessed by visiting the Events & Presentations section of the Company's website at www.invuity.com under Investors & Media. A replay of the webcast will be available shortly after the conclusion of the presentation and will be archived on the Company's website for 30 days following the presentation. About Invu...Read More
Researchers identify critical factors to minimize damage when using electrocautery near insulated pacing leads and demonstrate a reduced risk of damaging lead insulation with the use of PhotonBlade SAN FRANCISCO, May 14, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced the results of two studies that were published at the Scientific Sessions of the Heart Rhythm Society in Boston last week. The studies were co-authored by teams from Northwestern University and University of Pennsylvania and focused on the potential risk of damage to the insulation of pacing leads related to the use of electrocaute...Read More
SAN FRANCISCO, May 03, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announces financial results for the three months ended March 31, 2018. Q1 2018 Highlights First quarter 2018 revenue grew 5.3% to $9.5 million compared to revenue of $9.0 million in the first quarter of 2017. Disposable revenue in the first quarter of 2018 grew 21.7% to $8.6 million compared to $7.0 million in the first quarter of 2017. The number of accounts buying PhotonBlade® increased 23% from the fourth quarter of 2017 indicating continued strong adoption “In the first quarter we made progress towards our near and lon...Read More
“The light improves my visualization in the surgical field, allowing me to be more precise with my bone cuts and joint preparation”
“This is revolutionary technology that will change the way we do minimally invasive breast surgery. It is simply must have instrumentation to work more confident, and efficient in delicate anatomy.”
Anne Arundel Medical Center
“These retractors are a must for anyone looking to do nipple sparing mastectomies. I feel we can save significant amounts of surgical time since we can see better without the worry of burn injury or fire hazard often found with fiber optic light.”
New York, NY